News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published

被引：3
作者：
Stock, Jane [1 ]
机构：
[1] World Trade Ctr Goteborg, European Atherosclerosis Soc, Massans Gata 10, SE-41251 Gothenburg, Sweden
来源：
ATHEROSCLEROSIS | 2019年 / 291卷
关键词：
ESC; 2019; Congress; New guidelines; PCSK9 INHIBITOR EVOLOCUMAB; LOW LDL-CHOLESTEROL; RISK; EFFICACY; DISEASE; SAFETY;
D O I：
10.1016/j.atherosclerosis.2019.09.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 126
页数：3
相关论文
共 50 条
  • [41] Comments on the 2017 ESC/EACTS Guidelines on the Management of Valvular Heart Disease
    Evangelista, A.
    Alberto San Roman, J.
    Calvo, Francisco
    Gonzalez, Ariana
    Gomez Doblas, Juan Jose
    Revilla, Ana
    Antonio Castillo, Juan
    Gonzalez Juanatey, Carlos
    Gomez Doblas, Juan Jose
    Lopez Fernandez, Teresa
    Barreiro, Manuel
    Jose Oliva, Maria
    Galian Gay, Laura
    Serrador, Ana
    Jimenez Quevedo, Pilar
    Pan, Manuel
    Arnau Vives, Miguel A.
    Lopez Diaz, Javier
    Borras Perez, Xabier
    San Roman, Alberto
    Alfonso, Fernando
    Evangelista, Arturo
    Ferreira-Gonzalez, Ignacio
    Jimenez Navarro, Manuel
    Marin, Francisco
    Perez de Isla, Leopoldo
    Rodriguez Padial, Luis
    Sanchez Fernandez, Pedro Luis
    Sionis, Alessandro
    Vazquez Garcia, Rafael
    REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (02): : 67 - 73
  • [42] Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy
    Navarro, Manuel Jimenez
    Galian-Gay, Laura
    Avanzas, Pablo
    Ballesteros, Sara
    Garcia, Ana Gonzalez
    Mesa, Ernesto Gonzalez
    Bendayan, Isaac Martinez
    Domenech, Antonia Pijuan
    Prieto, Raquel
    Subirana, Teresa
    Bartha, Jose Luis
    Caro, Juan
    Delgado, Juan Luis
    Manso, Begona
    Rosillo, Sandra
    Zabala, J. Ignacio
    Alfonso, Fernando
    Ibanez, Borja
    Arribas, Fernando
    Congost, Gemma Berga
    Bueno, Hector
    Evangelista, Arturo
    Ferreira-Gonzalez, Ignacio
    Navarro, Manuel Jimenez
    Marin, Francisco
    de Isla, Leopoldo Perez
    Sambola, Antonia
    Vazquez, Rafael
    Viana-Tejedor, Ana
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (02): : 109 - 114
  • [43] Differences in the 2020 ESC versus 2019 ACC/AHA/HRS guidelines on atrial fibrillation
    Oraii, Alireza
    Bozorgi, Ali
    Tajdini, Masih
    EUROPEAN HEART JOURNAL, 2021, 42 (19) : 1820 - 1821
  • [44] European Society of Cardiology (ESC) Congress Report From Barcelona 2014
    Muramatsu, Takashi
    Ozaki, Yukio
    CIRCULATION JOURNAL, 2014, 78 (11) : 2610 - 2618
  • [45] 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: Established knowledge and evidence gaps
    Paneni, Francesco
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (01) : 5 - 10
  • [46] ST-segment elevation myocardial infarction: the new ESC Guidelines
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2018, 39 (02) : 75 - 78
  • [47] The new ESC guidelines 2021 on prevention of cardiovascular diseases Appeal for prevention
    Fegers-Wustrow, Isabel
    Wimbauer, Fritz
    Halle, Martin
    HERZ, 2022, 47 (01) : 55 - 62
  • [48] What is new in the management of peripheral arterial occlusive disease and diseases of the aorta?: Highlights of the ESC guidelines 2024
    Schulze-Bauer, Heike
    Staudacher, Moritz
    Steiner, Sabine
    Schlager, Oliver
    HERZ, 2025, 50 (01) : 25 - 33
  • [49] Comments on the 2012 Update of the ESC Guidelines for the Management of Atrial Fibrillation: What Is New and What Is Important for the Clinician?
    Andrikopoulos, George
    HELLENIC JOURNAL OF CARDIOLOGY, 2012, 53 (06) : 407 - 411
  • [50] The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients
    Rallidis, Loukianos S.
    ATHEROSCLEROSIS, 2020, 292 : 231 - 233
12345